Eiger BioPharmaceuticals Inc (EIGRQ)
2.552
-0.20
(-7.20%)
USD |
OTCM |
May 17, 15:32
Eiger BioPharmaceuticals Debt to Equity Ratio: -2.844 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.844 |
| September 30, 2023 | -25.40 |
| June 30, 2023 | 2.638 |
| March 31, 2023 | 1.135 |
| December 31, 2022 | 0.7164 |
| September 30, 2022 | 0.5021 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.3781 |
| March 31, 2022 | 0.3289 |
| December 31, 2021 | 0.4392 |
| September 30, 2021 | 0.3532 |
| June 30, 2021 | 0.2878 |
| March 31, 2021 | 0.2474 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-25.40
Minimum
Sep 2023
2.638
Maximum
Jun 2023
-1.768
Average
0.3657
Median
Debt to Equity Ratio Benchmarks
| AngioDynamics Inc | 0.00 |
| Pulse Biosciences Inc | -- |
| Outset Medical Inc | 2.112 |
| Allurion Technologies Inc | -0.5888 |
| Candel Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 38.83M |
| Total Liabilities (Quarterly) | 53.28M |
| Shareholders Equity (Quarterly) | -14.46M |
| Current Ratio | 0.7101 |
| Net Debt Paydown Yield | -3.62% |